0001104659-20-061251.txt : 20200514 0001104659-20-061251.hdr.sgml : 20200514 20200514092144 ACCESSION NUMBER: 0001104659-20-061251 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200514 DATE AS OF CHANGE: 20200514 EFFECTIVENESS DATE: 20200514 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management IV, LLC CENTRAL INDEX KEY: 0001704132 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-18415 FILM NUMBER: 20875567 BUSINESS ADDRESS: STREET 1: 600 MONTGOMERY STREET, SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 600 MONTGOMERY STREET, SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001704132 XXXXXXXX 03-31-2020 03-31-2020 false Foresite Capital Management IV, LLC

600 Montgomery Street, Suite 4500 San Francisco CA 94111

13F HOLDINGS REPORT 028-18415 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 05-14-2020 0 11 81136 INFORMATION TABLE 2 infotable.xml Aerie Pharmaceuticals, Inc. COM 00771V108 3074 227717 SH SOLE 227717 0 0 Biohaven Pharmaceutical Holding Company Ltd. COM G11196105 5321 156355 SH SOLE 156355 0 0 Blueprint Medicines Corporation COM 09627Y109 2298 50000 SH SOLE 50000 0 0 Cytokinetics Incorporated COM 23282W605 25670 2177292 SH SOLE 2177292 0 0 Fulcrum Therapeutics, Inc. COM 359616109 11924 998655 SH SOLE 998655 0 0 Insmed Incorporated COM 457669307 10874 678322 SH SOLE 678322 0 0 Kiniksa Pharmaceuticals, Ltd. COM G5269C101 1006 65000 SH SOLE 65000 0 0 Kura Oncology, Inc. COM 50127T109 925 93000 SH SOLE 93000 0 0 Myokardia, Inc. COM 62857M105 14411 307400 SH SOLE 307400 0 0 uniQure N.V. SHS N90064101 905 19082 SH SOLE 19082 0 0 Voyager Therapeutics, Inc. COM 92915B106 4728 516751 SH SOLE 516751 0 0